Chandler

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• COPD1 trial
• Hepatitis B1 trial
• Liver cirrhosis1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Completed3 trials
• Recruiting2 trials

Lead sponsor

• GlaxoSmithKline5 trials

Running trials

• Recruiting

  A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  NCT07221227· Phase 3· GlaxoSmithKline· Source

  Contact: Anita Kohli (principal investigator)

• Recruiting

  A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  NCT06920043· Phase 2· GlaxoSmithKline· Source

  Contact: Anita Kohli (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· Phase 2· GlaxoSmithKline· Source

• Completed

  Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

  NCT05630807· Phase 3· GlaxoSmithKline· Source

• Completed

  Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

  NCT04133909· Phase 3· GlaxoSmithKline· Source